Conservative care in Europe—nephrologists’ experience with the decision not to start renal replacement therapy

van de Luijtgaarden, Moniek W.M.; Noordzij, Marlies; van Biesen, Wim; Couchoud, Cecile; Cancarini, Giovanni; Bos, Willem-Jan W.; Dekker, Friedo W.; Gorriz, Jose L.; Iatrou, Christos; Wanner, Christoph; Finne, Patrik; Stojceva-Taneva, Olivera; Cala, Svjetlana; Stel, Vianda S.; Tomson, Charles; Jager, Kitty J.
October 2013
Nephrology Dialysis Transplantation;Oct2013, Vol. 28 Issue 10, p2604
Academic Journal
Background For some patients with end-stage renal disease (ESRD), providing conservative care until death may be an acceptable alternative for renal replacement therapy (RRT). We aimed to estimate the occurrence of conservative care in Europe and evaluated opinions about which factors nephrologists consider important in their decision not to offer RRT. Methods With a web-based survey sent to nephrologists in 11 European countries, we inquired how often RRT was not started in 2009 and how specific factors would influence the nephrologists’ decision to provide conservative care. We compared subgroups by nephrologist and facility characteristics using chi-square tests and Mann–Whitney U tests. Results We received 433 responses. Nephrologists decided to offer conservative care in 10% of their patients [interquartile range (IQR) 5–20%]. An additional 5% (IQR 2–10%) of the patients chose conservative care as they refused when nephrologists intended to start RRT. Patient preference (93%), severe clinical conditions (93%), vascular dementia (84%) and low physical functional status (75%) were considered extremely or quite important in the nephrologists’ decision to provide conservative care. Nephrologists from countries with a low incidence of RRT, not-for-profit centres and public centres more often scored these factors as extremely or quite important than their counterparts from high-incidence countries, for-profit centres and private centres. Conclusions Nephrologists estimated conservative care was provided to up to 15% of their patients in 2009. The presence of severe clinical conditions, vascular dementia and a low physical functional status are important factors in the decision-making not to start RRT. Patient preference was considered as a very important factor, confirming the importance of extensive patient education and shared decision-making.


Related Articles

  • Biosimilars and Renal Health Care in the Countries of Central and Eastern Europe. Tesař, Vladimír; Rychlik, Ivan // Kidney & Blood Pressure Research;Jul2007, Vol. 30 Issue S1, p2 

    The article discusses the relationship between biosimilars and its use in renal health care in Central and Eastern Europe (CEE). The economic development of CEE countries resulted to the increase in dialysis facilities. However, different standard of treatment using erythropoietin-stimulating...

  • Current State and Future Trends to Optimize the Care of African Americans with End-Stage Renal Disease. Harding, Kimberly; Mersha, Tesfaye B.; Webb, Fern J.; Vassalotti, Joseph a.; Nicholas, Susanne B.; Webb, Fern A // American Journal of Nephrology;Aug2017, Vol. 46 Issue 2, p156 

    Background: Chronic kidney disease is a progressive disease, which terminates in end-stage renal diseases (ESRD) that requires either dialysis or kidney transplantation for the patient to survive. There is an alarming trend in the disparities of ESRD in African Americans (AAs)....

  • Socio-cultural ‘change’: impact on nephrology. Brunkhorst, Reinhard // Nephrology Dialysis Transplantation;Aug2010, Vol. 25 Issue 8, p2430 

    The article discusses the socio-cultural developments and their effect on nephrology and its health care systems. It states that epidemiologic, demographic developments and loss of public and private solidarity have cause underfinanced medical care systems. It mentions that a direct effect on...

  • Is it possible to preserve the blood supply of erectile organs by anastomosis using the hypogastric artery in kidney transplantation? Zomorrodi, Afshar; Kakaei, Farzad; Zomorrodi, Sahar; Bagheri, Amin // International Journal of Nephrology & Renovascular Disease;Jul2017, Vol. 10, p191 

    Introduction: Three modalities for treating chronic kidney failure are peritoneal dialysis, hemodialysis, and kidney transplantation. Among them kidney transplantation is cost-efficient and leads to a somewhat normal quality of life. In this approach, most often the external iliac artery is...

  • Society News.  // Kidney & Blood Pressure Research;2010, Vol. 33 Issue 1, p85 

    The article presents information about the Polish Society of Nephrology. Founded in 1983, it is a professional association for nephrologists based in Poland. The association has more than 1,000 members in 8 regions today. One of the goals of the society is to make progress in clinical nephrology...

  • The cost of renal dialysis in a UK setting--a multicentre study. Keshwar Baboolal; Philip McEwan; Seema Sondhi; Piotr Spiewanowski; Jaroslaw Wechowski; Karen Wilson // Nephrology Dialysis Transplantation;Jun2008, Vol. 23 Issue 6, p1982 

    Background. The UK National Health Service (NHS) will fund renal services using Payment by Results (PbR), from 2009. Central to the success of PbR will be the creation of tariffs that reflect the true cost of medical services. We have therefore estimated the cost of different dialysis modalities...

  • Costs of dialysis—a regional population-based analysis. Icks, Andrea; Haastert, Burkhard; Gandjour, Afschin; Chernyak, Nadja; Rathmann, Wolfgang; Giani, Guido; Rump, Lars-Christian; Trapp, Rudolf; Koch, Michael // Nephrology Dialysis Transplantation;May2010, Vol. 25 Issue 5, p1647 

    Background. Population-based estimates of costs of renal replacement therapy are scarce in the literature. The aim of our study was to calculate the costs of long-term dialysis in 2006 on the basis of patient-specific data from a well-defined population in a region in western Germany (n = 310 757).

  • End-Stage Kidney Disease Without Dialysis. Moss, Alvin H.; Armistead, Nancy; Lupu, Dale // Health Affairs;Nov2015, Vol. 34 Issue 11, p2005 

    A letter to the editor is presented in response to Farrin Manian's Narratve Matters essay in the September 2015 which describes the death of his 87 year old father who chose not to start dialysis.

  • Neutrophil Gelatinase-Associated Lipocalin in Dialyzed Patients Is Related to Residual Renal Function, Type of Renal Replacement Therapy and Inflammation. Malyszko, Jolanta; Malyszko, Jacek S.; Koc-Zorawska, Ewa; Kozminski, Piotr; Mysliwiec, Michal // Kidney & Blood Pressure Research;2009, Vol. 32 Issue 6, p464 

    Neutrophil gelatinase-associated lipocalin (NGAL) has recently been proved useful in the quantitation of chronic kidney disease. A cross-sectional study was performed to assess NGAL in serum, urine and ultrafiltrate in relation to the type of renal replacement therapy and NGAL correlations with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics